EASE Score (Early Surgery Benefit in IE) Calculator
Clinical input
Enter the patient findings to reproduce the point tally in the legacy calculator.
TALLY
Clinical context
EASE refers to the randomized trial of early surgery versus conventional treatment in selected patients with left-sided native-valve infective endocarditis, severe valve disease, and vegetation diameter greater than 10 mm. The trial evaluated a treatment strategy; it did not validate the age / Staphylococcus aureus / heart-failure point system implemented in the original PHP file.
Practical interpretation
- Do not interpret this arithmetic total as a probability of benefit, mortality estimate, or validated surgical indication.
- Urgent surgical indications and timing should be assessed promptly by the Endocarditis Team using the patient's full clinical and imaging findings and current guidelines.
- The trial population was selected and its findings should not be generalized automatically to all infective endocarditis presentations.
Evidence reference
Kang DH, et al. Early Surgery versus Conventional Treatment for Infective Endocarditis. N Engl J Med. 2012;366:2466–2473.
DOI: 10.1056/NEJMoa1112843 · PMID: 22738096
The prior source citation to “Agarwal S, et al. … JACC. 2021;77:1234–1245” was not verified and has therefore been removed rather than treated as evidence for this point system.
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.